Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women???s Health Initiative Randomized Controlled Trial
Year: 2002
Type: article
Study design: Clinical Trial
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: estrogen plus progestin, hormone replacement therapy, Women's Health Initiative, coronary artery disease, breast cancer, invasive breast cancer, stroke, venous thromboembolism, pulmonary embolism, deep vein thrombosis, stroke mortality, fracture risk, hip fracture, conjugated equine estrogens, medroxyprogesterone acetate, hysterectomy
Open Access status: closed
Funders: Pfizer, NIH Clinical Center
OpenAlex ID: W4240373784
